Paul Tang

Associate Professor

Mayo Clinic

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Paul Tang is an Associate Professor at Mayo Clinic in the United States. His primary research areas include cardiac support devices, heart transplantation, and advanced heart failure interventions. He has published recently on topics such as cardiac index predictors after LVAD implantation and the implications of donor heart ischemic times in transplantation outcomes.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Ming-Sing Si

Associate Professor

David Geffen School of Medicine at UCLA

UNITED STATES

View details

Jessica Millar

University of Michigan

UNITED STATES

View details

Michael Mathis

University of Michigan

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paul Tang

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Active and Passive Cardiac Index as Complementary Predictors of Outcomes After LVAD Implantation

Reply: “Forget me not,” an appeal from the mitral valve in the left ventricular assist device-supported circulation

Transmitral myectomy for mid-cavity obstruction and mitral replacement for rheumatic disease

Preoperative passive venous pressure-driven cardiac function determines left ventricular assist device outcomes

Mitral Interventions in Heart Failure

Determining optimal donor heart ischemic times in adult cardiac transplantation

Untargeted metabolomics identifies succinate as a biomarker and therapeutic target in aortic aneurysm and dissection

Left Ventricular Assist Device Implantation in Patients with Preoperative Severe Mitral Regurgitation

Response to letter by Miyauchi et al

Risk factors for heart transplant survival with greater than 5 h of donor heart ischemic time

Fate of preoperative moderate mitral regurgitation following left ventricular assist device implantation

Commentary: Significant Mitral Regurgitation at the Time of LVAD Implantation: Looking Together in the Same Direction But We Need to Look Closer

Commentary: A Novel Technique of Percutaneous Left Ventricular Assist Device Deactivation: Just Plug and Stop the Pump or Remove it? That is the Question

Collaborators (3)

Ming-Sing Si

Jessica Millar

Michael Mathis

Make your next move.